2-Difluoromethylornithine (DFMO), an enzyme-activated irreversible inhibitor of ornithine decarboxylase, causes marked changes in the polyamine metabolism of ventral prostate when given to adult rats in drinking water (20 g/1) for 3 consecutive days. A 90% inhibition of ornithine decarboxylase activity is accompanied by approx. 80% decreases of the concentrations of putrescine and spermidine and by a 36% decrease in spermine. Concomitantly, S-adenosylmethionine decarboxylase activity increases 7-fold and the concentration of decarboxylated S-adenosylmethionine 450-fold. When DFMO is given to immature rats for 12 consecutive days the above described changes are accompanied by a marked reduction in the age-dependent increases of the wet weight and RNA and DNA contents of the ventral prostate. In adult rats DFMO decreases the weight and RNA content of the ventral prostate within 4 days by 32% and 24% respectively and maintains them constant for the next 19 days. After 23 days of treatment, the prostatic weight is 46% of that of control animals of the same age, whereas the weights of other organs are only slightly decreased. Cytological studies carried out at this time show that DFMO reduces the size of both prostatic acini and the epithelial cells lining the acini.
Printed in Great Britain
Effect on prostatic growth of 2-difluoromethylornithine, an effective inhibitor of ornithine decarboxylase 2-Difluoromethylornithine (DFMO), an enzyme-activated irreversible inhibitor of ornithine decarboxylase, causes marked changes in the polyamine metabolism of ventral prostate when given to adult rats in drinking water (20 g/1) for 3 consecutive days. A 90% inhibition of ornithine decarboxylase activity is accompanied by approx. 80% decreases of the concentrations of putrescine and spermidine and by a 36% decrease in spermine. Concomitantly, S-adenosylmethionine decarboxylase activity increases 7-fold and the concentration of decarboxylated S-adenosylmethionine 450-fold. When DFMO is given to immature rats for 12 consecutive days the above described changes are accompanied by a marked reduction in the age-dependent increases of the wet weight and RNA and DNA contents of the ventral prostate. In adult rats DFMO decreases the weight and RNA content of the ventral prostate within 4 days by 32% and 24% respectively and maintains them constant for the next 19 days. After 23 days of treatment, the prostatic weight is 46% of that of control animals of the same age, whereas the weights of other organs are only slightly decreased. Cytological studies carried out at this time show that DFMO reduces the size of both prostatic acini and the epithelial cells lining the acini.
Large amounts of polyamines and high activities of their biosynthetic enzymes are found in rat ventral prostate (Williams-Ashman et al., 1975a; Janne et al., 1978) . There are only minor changes in polyamine concentrations during age-dependent growth of rat ventral prostate . In the castrated rat, testosterone-induced prostatic regrowth is accompanied by an increase of polyamine concentrations (Pegg et al., 1970) . Under these conditions, increases in the prostatic content of RNA but not of DNA correlate with increases in spermidine but not in spermine concentrations (Williams-Ashman et al., 1975b) . However, the interpretation of these results is complicated by the presence of high concentrations of polyamines in prostatic secretions , which makes it difficult to estimate the intracellular content of polyamines.
Several authors have suggested that concentrations of polyamines and activities of their biosynthetic enzymes could reflect secretory functions of the prostatic gland rather than its growth (Fuller et al., 1975; Williams-Ashman et al., 1975b; (Metcalf et al., 1978) and in vivo (Danzin et al., 1979a) , of ornithine decarboxylase (EC 4.1.1.17), the enzyme responsible for the biosynthesis of putrescine. The inhibitor slowed the testosterone-induced weight gain of the ventral prostate in castrated rats (Danzin et al., 1979b) . This slowing was mainly due to inhibition of the restoration of prostatic secretions, whereas the testosterone-stimulated cellular hypertrophy was only marginally affected and the cellular proliferation was not affected at all.
We now report that prolonged administration of DFMO to intact rats decreases the polyamine concentrations and the volume of secretions in the ventral prostate and suppresses its normal agedependent hypertrophic and hyperplasic growth.
Experimental

Chemicals
The following compounds were purchased: tetrasodium EDTA (Calbiochem, San (Metcalf et al., 1978) .
A nimals
Male Sprague-Dawley rats were purchased from Charles River, Saint-Aubin-les-Elbeuf, France. Animals had access to a standard diet ad libitum and were kept on a constant 12 h light/ 12 h dark schedule. Treated animals received a solution of DFMO in water (20 g/l) as the sole drinking fluid, resulting in a daily intake of approx. 2 g/kg body wt. Rats were killed by decapitation between 11 :00 and 12:00h to minimize effects due to diurnal fluctuations.
Preparation oftissue extracts
The ventral prostate and other organs were removed, freed of fat and connective tissue, weighed and frozen in liquid N2. The organs were homogenized at 4°C in 5 ml of 5% (w/v) trichloroacetic acid and the homogenates were centrifuged at 3000g. The supernatants were used for polyamine and amino acid determinations, and the precipitates were used for nucleic acid measurements. In parallel experiments, ventral prostate homogenates were made in 5 vol. of 30mM-sodium phosphate buffer, pH 7.1, containing 0.1 mM-EDTA, 0.1 mM-pyridoxal phosphate and 5 mM-dithiothreitol for measurements of enzyme activities.
Polyamine and amino acid determinations
The supernatants were filtered through a Millipore membrane (pore size 0.22,um), before measurement of their polyamine content with a Durrum D-500 amino acid analyser (Durrum Instruments Corp., Palo Alto, CA, U.S.A.) by the method of Marton et al. (1974) as modified by Bartos et al. (1977) .
Omithine and DFMO were determined by a modification of the method of Lee (1973) , with a Liquimat II (Kontron, Paris, France) amino-acid analyser equipped with a 2.5 mm-internal-diameter glass column filled to a height of 30cm with Durrum DC-4 cation-exchange resin.
S-Adenosylmethionine, S-adenosylhomocysteine and decarboxylated S-adenosylmethionine [Sadenosyl-(5 ')-3-methylthiopropylamine were determined by reversed-phase ion-pair high-pressure liquid chromatography (Wagner et al., 1981 ) with a pBondapack C18 column (10,um particle size; 3.9mm x 30cm). A linear gradient, leading in 30 min from an eluent consisting of a mixture of 47:3 (v/v) NaH2PO4 (O.1 M) and acetonitrile (pH 2.5) to one consisting of a mixture of 37:13 (v/v) NaH2PO4 (0.1 M) and acetonitrile (pH 3.1), was used at a flow rate of 1.5 ml/min and a temperature of 280C. Octane sulphonic acid (8mM) in both eluents was used as ion-pairing agent. The u.v. absorption was monitored at 254 nm. The high-pressure liquid chromatograph consisted of models 6000 A and 660 as solvent delivery system, of a WISP 710 instrument, as automatic sample injector, and of model 440 as u.v. detector, all from Waters Associates (Milford, MA, U.S.A.). The signal was recorded on an SP. 4100 digital integrator from Spectra Physics (Santa-Clara, CA, U.S.A.).
Nucleic acid determination
The procedure for measuring RNA and DNA described by Schneider (1957) was modified as follows. The trichloroacetic acid-precipitated material was resuspended in 2 ml of 0.3 M-KOH for 20h at 37°C. Thereafter, 5ml of 1.6M-HC104 was added, and the suspension was cooled to 0°C during 1 h followed by centrifugation at 3000g for 10min. The supernatant was used to determine RNA by the orcinol reaction (Mejbaum, 1939) with purified yeast RNA as standard. The precipitate was resuspended in 2 ml of 0.5M-HCl04 and digested for 20 min at 900 C. The suspension was centrifuged at 2000g for 10min. The supernatant was used to determine DNA by the diphenylamine method (Burton, 1968) with calf thymus DNA as reference material.
Assays of ornithine decarboxylase and S-adenosylmethionine decarboxylase activities
The homogenates prepared as described above were centrifuged at 105 000g. Ornithine decarboxylase activity was measured in the dialysed supernatant, essentially as described by Ono et al. (1972) . S-Adenosylmethionine decarboxylase activity was measured in the same supernatant, in the presence of 2.5 mM-putrescine, by the method of Janne & Williams-Ashman (1971) . One unit of either ornithine decarboxylase or S-adenosylmethionine decarboxylase activity is defined as the amount of enzyme catalysing the formation of 1 nmol of C02/30min. Proteins were measured by the method of Lowry et al. (1951) with bovine serum albumin as standard.
1982
Staining ofprostate gland sections Ventral prostates were fixed for 20h in Carnoy's medium and sections were stained with the modified Gomori's trichrome (Haematoxylin/Light Green/ Eosin) in a similar way to the procedure described by Mangan et al. (1973) .
Results
Effects of 3 daYs of DFMO administration on the polvamine metabolism ofrat ventral prostate DFMO given over 3 days to rats in their drinking water (20g/1) produced a significant (24%) decrease of wet weight of the ventral prostate (Table 1) . Ornithine decarboxylase activity was inhibited by 90% and there were marked decreases in putrescine and spermidine concentrations and a lesser decrease in spermine concentration. S-Adenosylmethionine decarboxylase activity increased 7-fold and the concentration of decarboxylated S-adenosylmethionine 450-fold. The concentrations of ornithine and of S-adenosylmethionine increased slightly, whereas the concentration of S-adenosylhomocysteine was not significantly affected (Table 1) .
Effects of chronic administration of DFMO on the growth ofrat ventral prostate Immature rats (80g, 4 weeks old) were given DFMO (20g/litre, in water) as the only drinking fluid for 12 days. The concentrations of putrescine, spermidine and spermine in the ventral prostate were decreased to 30, 6 and 76% respectively of the values from matched controls (Table 2 ). This decrease in polyamine concentration was accompanied by a 400-fold increase in the concentration of decarboxylated S-adenosylmethionine.
The concentration of S-adenosylmethionine was not modified, whereas the concentrations of Sadenosylhomocysteine and ornithine were slightly higher than in the same tissue from control animals.
The DFMO-induced metabolic perturbations were accompanied by a marked reduction in the growth of the ventral prostate (Table 2) . In treated animals, the age-dependent weight increase of this gland was only 27% of that of control animals. The corresponding increase in RNA content was similarly affected, whereas the increase in DNA content was completely suppressed during DFMO treatment.
In adult rats (300g; 10 weeks old), polyamine concentrations, nucleic acid contents and growth of the ventral prostate were measured at various times during DFMO treatment. Within 4 days of treatment with DFMO, the concentrations of putrescine, spermidine and spermine fell to 2, 13 and 65% respectively of the control values (Table 3 ) and continued to decrease slowly thereafter. After 23 days of treatment, they reached 1, 5 and 49% respectively of the values for control animals of the same age. The wet weight and RNA content of the ventral prostate decreased within 4 days below the starting values and remained constant thereafter, whereas these parameters steadily increased in the control animals. At the end of treatment, the wet weight of ventral prostate was only 46% of that from control animals of the same age and the RNA content of this gland was 60% of that of controls. In adult rats, the DNA content of the ventral prostate changes only slightly with increasing age Heyns et al., 1978) ; DFMO had no significant effect on it.
After 23 days of DFMO administration, several (Table 4) . However, the organ weight/body weight ratio was significantly decreased only for the ventral prostate. Table 4 . Effects ofchronic administration ofDFMO on absolute and relative organ weights ofadult rats The wet weights of various organs were measured in rats treated for 23 days and in control rats (see Table 3 ). For each organ, the first line indicates the control value and the second line the value obtained from treated animals. Each value is the mean + S.E.M. of five animals. Table 5 . Effects on prostatic morphology ofchronic administration ofDFMO in adult rats
The treated animals received DFMO dissolved in drinking water (20g/1). Histological studies were performed on ventral prostates of four treated and four control animals. The tissues were sectioned at 4,um and stained as described in the Experimental section. Acini diameters (measured from the length and width of the theoretical rectangles that would enclose these areas) and heights of epithelial cells lining the acini were measured with an ocular micrometer in 140 to 170 acini/prostate, located in five different regions. Values in the (Janne et al.. 1978) , including prostatic adenoma cells (Mamont et al., 1978) , and has been suggested for experimental tumours of animals treated with DFMO (KochWeser et al., 1981) .
The 450-fold increase in decarboxylated Sadenosylmethionine concentration that accompanies the decrease in polyamine concentrations in treated animals also deserves attention. Spermidine has a negative regulatory role on S-adenosylmethionine decarboxylase activity in vivo, i.e. the depletion of spermidine concentration due to inhibition of ornithine decarboxylase is followed by an increase in S-adenosylmethionine decarboxylase activity in cultured cells (Alhonen-Hongisto, 1980; Mamont et al., 1981) . Spermidine depletion seems to have a similar effect in the ventral prostate, even though resting S-adenosylmethionine decarboxylase activity is already much higher in the ventral prostate than in other tissues (Raina et al., 1976) . The increase in S-adenosylmethionine decarboxylase activity is accompanied by a 450-fold increase in the concentration of decarboxylated S-adenosylmethionine. It is noteworthy that under similar conditions, decarboxylated S-adenosylmethionine concentration is not affected in the pancreas and is increased only 4-fold in testis and 40-fold in the thymus (Wagner et al., 1981) .
The marked accumulation of decarboxylated S-adenosylmethionine in the prostate is presumably due both to the observed increase in S-adenosylmethionine decarboxylase activity and to the reduction in the biosynthesis of putrescine and spermidine. The role of decarboxylated S-adenosylmethionine as donor of the aminopropyl moiety in the biosynthesis of spermidine and spermine is well established (Janne et al., 1978) , but nothing is known about its catabolism. It does not usually accumulate in mammalian cells (Hibasami et al., 1980) . Its enormous accumulation in ventral prostate during treatment with DFMO indicates slow catabolism and excretion. An important metabolic consequence of the accumulation of decarboxylated S-adenosylmethionine is trapping of adenine. In normal cells, the decarboxylated S-adenosylmethionine is transformed into 5 '-methylthioadenosine and spermidine or spermine by spermidine synthase and spermine synthase (Janne et al., 1978) . In the prostate, a high activity of methylthioadenosine phosphorylase, which cleaves methylthioadenosine into methylthioribose 1-phosphate and adenine, was reported by Pegg & Williams-Ashman (1969) and by Seidenfeld et al. (1980) . The suggested function of the methylthioadenosine phosphorylase is to allow metabolic recycling of adenine derived from decarboxylated S-adenosylmethionine (Williams-Ashman, 1981) . Decarboxylated Sadenosylmethionine cannot be transformed into methylthioadenosine in the absence of putrescine and thus adenine is not recycled. These conditions could be similar to those observed after ethionine administration to rats, when the resulting accumulation of S-adenosylethionine leads to the depletion of hepatic ATP due to trapping of adenine (Shull et al., 1966) . Therefore, the suppression of nucleic acid accumulation within the ventral prostate in DFMO-treated rats may be partly explained by failure to synthesize adenine nucleotides de novo at a sufficiently high rate to compensate for the trapping of adenine by decarboxylated S-adenosylmethionine.
Another factor, not directly related to polyamine depletion in the ventral prostate, may have influenced prostatic growth. Chronic treatment of rats with DFMO causes a slight but significant slowing of body weight gain compared with control rats, presumably by diminishing food intake. Underfeeding tends to affect growth and secretory activity of the male accessory organs, probably due to a decreased testosterone production by the testes (Mann, 1974) . However, this mechanism seems to be relatively unimportant, since the absolute and relative weights of the coagulating gland, of the seminal vesicle with or without secretions and of the testis were only slightly or not at all affected.
In a previous report (Danzin et al., 1979b) we have shown that in castrated rats, DFMO did not affect the testosterone-induced hypertrophy and hyperplasia of epithelial cells. It retarded RNA accumulation only to a slight extent, but markedly slowed restoration of the prostatic secretions. However, in the present study DFMO affected the age-dependent increase of DNA and RNA contents and the height of epithelial cells. The discrepancy between the two studies might be due to the use of superphysiological doses of testosterone in castrated rats. Thus, polyamines may have only a contributory role in the action of steroid androgens on the biosynthesis of nucleic acids. Such a contributory role has already been suggested for the stimulation of casein synthesis by glucocorticoids in the mammary gland of rabbit (Houdebine et al., 1978) and rat (Bolander & Topper, 1979) .
